A Non-Interventional Multicenter Study of First-Line Bevacizumab in Combination with Chemotherapy in Patients with Metastatic Colorectal Cancer in Lebanon.
Sally TemrazFadi NasrJoseph KattanDany AbigergesWalid MoukademFadi FarhatLayal MaatoukGeorges ChahineAli ShamseddinePublished in: Biologics : targets & therapy (2022)
The trial further substantiated the efficacy and safety of bevacizumab and chemotherapy in the first-line treatment of mCRC patients in Lebanon.